Today, Recombinetics named Dr. Tad Sonstegard the first Chief Executive Officer of its wholly-owned subsidiary, Acceligen.  Sonstegard will lead Acceligen’s efforts to raise capital and strategic partnerships for its products that genetically improve the health and well-being of livestock and aquaculture. With Acceligen now entering into significant commercial transactions, Sonstegard’s [...]